Samsung announced that it has acquired medical imaging company NeuroLogica, part of the multinational conglomerate’s plans to build a leading medical technology business. Terms of the deal were not disclosed.
“The acquisition of NeuroLogica is another important step in the expansion of Samsung’s medical imaging business,” said Tod Pike, senior VP at Samsung’s Enterprise Business Division. The press release also stated that the purchase is part of Samsung’s plans to expand its medical imaging business. Boston-based NeuroLogica was founded in 2004 and is known for its portable computed tomography (CT) scanners, including the BodyTom and CereTom.
Samsung is busy expanding into the medical device sector and plans to become one of the world’s leading medical equipment by 2020. Last November, Samsung Electronics America, a subsidiary of Samsung, announced the addition of Samsung Health & Medical Equipment, which merged employees from Samsung Medison America, its ultrasound machine manufacturer, into its Enterprise Business Division. Samsung had acquired Medison in 2010 and its medical technology business as a “key element in Samsung’s 2020 vision to explore new areas of growth,” said the company at the time.
NeuroLogica Corporation, located in the Boston metro area, conceives, designs, engineers, manufactures and markets innovative medical imaging equipment for healthcare facilities and private practices worldwide.